Stay updated with breaking news from Cell Source. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CHICAGO, April 28, 2021 /PRNewswire/ -- According to the new market research report "Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound
Darlene Soave Joins Cell Source's Board of Directors News provided by Share this article Share this article NEW YORK, April 1, 2021 /PRNewswire/ -- Cell Source, Inc. (OTC: CLCS) ("Cell Source" or "the Company"), is the world leader in Veto Cell based innovative immunotherapy and today announced that Darlene Soave has been appointed to the Company's Board of Directors, effective March 25, 2021. Veto Cells, in different mouse models, have shown that they have the potential to safely facilitate mismatched donor stem cell (e.g. bone marrow) transplants and organ transplants. In addition, in pre...
Cell Lysis/Cell Fractionation Market worth $4.1 billion by 2026 - Exclusive Report by MarketsandMarkets "Cell Lysis/Cell Fractionation Market by Product (Consumables (Enzymes, Detergent), Instruments (Sonicators)), Cell Type (Mammalian), Application (Protein Purification), End User (Biopharmaceutical & Biotechnology Companies) - Global Forecast to 2026", published by MarketsandMarkets, the global Cell Lysis Market Size is projected to reach USD 4.1 billion by 2026 from USD 2.9 billion in 2021, at a CAGR of 7.2%. Browse in-depth TOC on 150 - Tables Download PDF Brochure: https://www.markets...
Consumables accounted for the larger share of the cell lysis market in 2020 Based on the product, the market is segmented into consumables and instruments. In 2020, the consumables segment accounted for the larger share of the cell fractionation market. The large share of this segment can be attributed to repeated purchase and high consumption, the high prevalence of diseases, and increasing funding for cell-based research. By cell type, the mammalian cells segment accounted for the largest market share in 2020 Based on the cell type, the market is segmented into mammalian cell, microbial cel...
/PRNewswire/ -- Cell Source, Inc. (OTC: CLCS) ("Cell Source" or the Company"), the world leader in Veto Cell based immunotherapy technologies that can safely...